IC
ALNY icon

IEQ Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History

IEQ Capital’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.64M Sell
15,410
-7,461
-33% -$2.25M 0.02% 522
2026
Q1 		$7.57M Sell
22,871
-42,034
-65% -$14.3M 0.04% 410
2025
Q4 		$25.8M Buy
64,905
+2,728
+4% +$1.21M 0.08% 158
2025
Q3 		$28.4M Buy
62,177
+56,055
+916% +$22.8M 0.09% 123
2025
Q2 		$2M Sell
6,122
-37,892
-86% -$10.5M 0.01% 643
2025
Q1 		$11.9M Buy
44,014
+5,208
+13% +$1.34M 0.09% 168
2024
Q4 		$9.13M Buy
38,806
+34,613
+825% +$9.1M 0.09% 144
2024
Q3 		$1.15M Buy
4,193
+1,153
+38% +$300K 0.01% 498
2024
Q2 		$739K Buy
3,040
+1,550
+104% +$245K 0.01% 545
2024
Q1 		$223K Buy
+1,490
New +$249K ﹤0.01% 855
2023
Q4 		– Sell
-1,540
Closed -$273K – 931
2023
Q3 		$273K Buy
1,540
+41
+3% +$7.82K 0.01% 751
2023
Q2 		$285K Buy
1,499
+194
+15% +$38.5K 0.01% 695
2023
Q1 		$261K Sell
1,305
-142
-10% -$29.8K 0.01% 757
2022
Q4 		$344K Buy
1,447
+55
+4% +$11.7K 0.01% 596
2022
Q3 		$279K Buy
+1,392
New +$266K 0.01% 682

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IEQ Capital's ALNY Position: Q2 2026 in Review

IEQ Capital reduced its Alnylam Pharmaceuticals (ALNY) stake by 33% in Q2 2026, selling an estimated $2.25M and leaving 15,410 shares worth $4.64M. The position accounts for 0.02% of the portfolio, ranked #522.

IEQ Capital first reported a position in ALNY in Q3 2022 and has held it in 15 quarters since. The position peaked at $28.4M in Q3 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • IEQ Capital held 15,410 shares of Alnylam Pharmaceuticals worth $4.64M as of Q2 2026.
  • IEQ Capital sold 7,461 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $2.25M.
  • Alnylam Pharmaceuticals made up 0.02% of IEQ Capital's portfolio in Q2 2026, its #522 holding.
  • IEQ Capital first reported a position in Alnylam Pharmaceuticals in Q3 2022 and has held it in 15 quarters since.
  • IEQ Capital's Alnylam Pharmaceuticals position peaked at $28.4M in Q3 2025.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.